Ashina M, Hansen JM, á Dunga BO, Olesen J. (2017) Human models of migraine — short-term pain for long-term gain. Nat Rev Neurol. 13(12):713–724
Article
PubMed
Google Scholar
Goadsby PJ (2009) The vascular theory of migraine—a great story wrecked by the facts. Brain 132(1):6–7
Article
PubMed
Google Scholar
Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 97(2):553–622
Article
PubMed
PubMed Central
Google Scholar
Schulte LH, Menz MM, Haaker J, May A (2020) The migraineur's brain networks: Continuous resting state fMRI over 30 days. Cephalalgia. 40(14):1614–1621
Article
PubMed
Google Scholar
Schulte LH, Mehnert J, May A (2020) Longitudinal Neuroimaging over 30 Days: Temporal Characteristics of Migraine. Ann Neurol. 87(4):646–651
Article
PubMed
Google Scholar
Edvinsson J, Viganò A, Alekseeva A, Alieva E, Arruda R, De Luca C et al (2020) The fifth cranial nerve in headaches. J Headache Pain. 21:1–17
Article
Google Scholar
Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 358(9294):1668–1675
Article
CAS
PubMed
Google Scholar
Tepper SJ, Rapoport AM, Sheftell FD (2002) Mechanisms of Action of the 5-HT1B/1D Receptor Agonists. Arch Neurol. 59(7):1084–1088
Article
PubMed
Google Scholar
Saxena PR, Ferrari MD (1989) 5-HT(1)-like receptor agonists and the pathophysiology of migraine. Trends Pharmacol Sci. 10(5):200–204
Article
CAS
PubMed
Google Scholar
Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33(1):48–56
Article
CAS
PubMed
Google Scholar
Edvinsson JC, Reducha P, Sheykhzade M, Warfvinge K, Haanes KA, Edvinsson L (2021) Neurokinins and their receptors in the rat trigeminal system: Differential localization and release with implications for migraine pain. Mol Pain 00
Durham PL, Russo AF (1999) Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J Neurosci 19(9):3423–3429
Article
CAS
PubMed
PubMed Central
Google Scholar
Goadsby PJ (1998) Serotonin 5-HT1B/1D Receptor Agonists in Migraine. CNS Drugs. 10(4):271–286
Article
CAS
Google Scholar
Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine—current understanding and treatment. N Engl J Med 346(4):257–270
Article
CAS
PubMed
Google Scholar
Nilsson T, Longmore J, Shaw D, Olesen IJ, Edvinsson L (1999) Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry. Br J Pharmacol. 128(6):1133–1140
Article
CAS
PubMed
PubMed Central
Google Scholar
Razzaque Z, Heald MA, Pickard JD, Maskell L, Beer MS, Hill RG et al (1999) Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation. Br J Clin Pharmacol. 47(1):75–82
Article
CAS
PubMed
PubMed Central
Google Scholar
Edvinsson L, Uddman E, Wackenfors A, Davenport A, Longmore J, Malmsjö M (2005) Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect. Clin Sci 109(3):335–342
Article
CAS
Google Scholar
Longmore J, Maguire JJ, MacLeod A, Street L, Schofield WN, Hill RG (2000) Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery. Br J Clin Pharmacol 49(2):126–131
Article
CAS
PubMed
PubMed Central
Google Scholar
Rebeck GW, Maynard KI, Hyman BT, Moskowitz MA (1994) Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Proc Natl Acad Sci 91(9):3666–3669
Article
CAS
PubMed
PubMed Central
Google Scholar
Hou M, Kanje M, Longmore J, Tajti J, Uddman R, Edvinsson L (2001) 5-HT1B and 5-HT1D receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res 909(1-2, 112):–20
Goadsby PJ, Edvinsson L (1994) Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90. Headache. 34(7):394–399
Article
CAS
PubMed
Google Scholar
Clemow DB, Johnson KW, Hochstetler HM, Ossipov MH, Hake AM, Blumenfeld AM (2020) Lasmiditan mechanism of action–review of a selective 5-HT 1F agonist. J Headache Pain. 21(1):1–13
Article
Google Scholar
Rubio-Beltrán E, Labastida-Ramírez A, Haanes KA, van den Bogaerdt A, Bogers AJ, Zanelli E et al (2019) Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan. Br J Pharmacol 176(24):4681–4695
Article
PubMed
PubMed Central
Google Scholar
Labastida-Ramírez A, Rubio-Beltrán E, Haanes KA, Chan KY, Garrelds IM, Johnson KW et al (2020) Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system. Pain. 161(5):1092
Article
PubMed
PubMed Central
Google Scholar
Shepheard S, Edvinsson L, Cumberbatch M, Williamson D, Mason G, Webb J et al (1999) Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370. Cephalalgia. 19(10):851–858
Article
CAS
PubMed
Google Scholar
Goadsby P, Classey J (2003) Evidence for serotonin (5-HT) 1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input. Neuroscience 122(2):491–498
Article
CAS
PubMed
Google Scholar
Gomez-Mancilla B, Cutler N, Leibowitz M, Spierings E, Klapper J, Diamond S et al (2001) Safety and Efficacy of PNU-142633, a Selective 5-HT1D Agonist, in Patients with Acute Migraine. Cephalalgia 21(7):727–732
Article
CAS
PubMed
Google Scholar
Ferrari MD. (2001) Re Gomez-Mancilla et al. Safety and efficacy of PNU-142633, a selective 5-HT(1D) agonist, in patients with acute migraine. Cephalalgia.;21(7):711.
Article
CAS
PubMed
Google Scholar
Mathiau P, Bakalara N, Aubineau P (1994) Tryptophan hydroxylase can be present in mast cells and nerve fibers of the rat dura mater but only mast cells contain serotonin. Neurosci Lett 182(2):133–137
Article
CAS
PubMed
Google Scholar
Clark MS, Russo AF (1998) Measurement of tryptophan hydroxylase mRNA levels by competitive RT-PCR. Brain Res Protocol 2(4):273–285
Article
CAS
Google Scholar
Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671-5.
Haanes KA, Labastida-Ramirez A, Blixt FW, Rubio-Beltran E, Dirven CM, Danser AH et al (2019) Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models. Cephalalgia. 39(11):1421–1434
Article
PubMed
Google Scholar
Hansen-Schwartz J, Hoel NL, Zhou M, Xu C-B, Svendgaard N-A, Edvinsson L (2003) Subarachnoid Hemorrhage Enhances Endothelin Receptor Expression and Function in Rat Cerebral Arteries. Neurosurgery. 52(5):1188–1195
PubMed
Google Scholar
Selkirk J, Scott C, Ho M, Burton M, Watson J, Gaster L et al (1998) SB-224289–a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. Br J Pharmacol 125(1):202–208
Article
CAS
PubMed
PubMed Central
Google Scholar
Levy D (2009) Migraine pain, meningeal inflammation, and mast cells. Curr Pain Headache Rep 13(3):237–240
Article
PubMed
Google Scholar
Chouchkov C, Lazarov N, Davidoff M (1988) Serotonin-like immunoreactivity in the cat trigeminal ganglion. Histochemistry 88(3):637–639
Article
CAS
PubMed
Google Scholar
Keller JT, Marfurt CF (1991) Peptidergic and serotoninergic innervation of the rat dura mater. J Comp Neurol 309(4):515–534
Article
CAS
PubMed
Google Scholar
Frederiksen SD, Warfvinge K, Ohlsson L, Edvinsson L (2018) Expression of pituitary adenylate cyclase-activating peptide, calcitonin gene-related peptide and headache targets in the trigeminal ganglia of rats and humans. Neuroscience 393:319–332
Article
CAS
PubMed
Google Scholar
Edvinsson JC, Warfvinge K, Krause DN, Blixt FW, Sheykhzade M, Edvinsson L et al (2019) C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system. J Headache Pain 20(1):1–10
Article
CAS
Google Scholar
Edvinsson L, Haanes KA (2021) Identifying New Antimigraine Targets: Lessons from Molecular Biology. Trends Pharmacol Sci. 42(4):217–225
Article
CAS
PubMed
Google Scholar
Haanes KA, Edvinsson L (2019) Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets. CNS Drugs. 33(6):525–537
Article
CAS
PubMed
Google Scholar
Amrutkar DV, Ploug KB, Hay-Schmidt A, Porreca F, Olesen J, Jansen-Olesen I (2012) mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system. Pain 153(4):830–838
Article
CAS
PubMed
Google Scholar
Flegel C, Schobel N, Altmuller J, Becker C, Tannapfel A, Hatt H et al (2015) RNA-Seq Analysis of Human Trigeminal and Dorsal Root Ganglia with a Focus on Chemoreceptors. PLoS One 10(6):e0128951
Article
PubMed
PubMed Central
Google Scholar
Reinhard JF, Liebmann JE, Schlosberg AJ, Moskowitz MA (1979) Serotonin neurons project to small blood vessels in the brain. Science 206(4414):85–87
Article
CAS
PubMed
Google Scholar
Edvinsson L, Degueurce A, Duverger D, MacKenzie ET, Scatton B (1983) Central serotonergic nerves project to the pial vessels of the brain. Nature. 306(5938):55–57
Article
CAS
PubMed
Google Scholar
Chan-Palay V (1976) Serotonin axons in the supra-and subependymal plexuses and in the leptomeninges; their roles in local alterations of cerebrospinal fluid and vasomotor activity. Brain Res 102(1):103–130
Article
CAS
PubMed
Google Scholar
Bradley SR, Pieribone VA, Wang W, Severson CA, Jacobs RA, Richerson GB (2002) Chemosensitive serotonergic neurons are closely associated with large medullary arteries. Nature Neurosci 5(5):401–402
Article
CAS
PubMed
Google Scholar
Lipton RB, Lombard L, Ruff DD, Krege JH, Loo LS, Buchanan A et al (2020) Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study. J Headache Pain 21(1):20
Article
CAS
PubMed
PubMed Central
Google Scholar
Brandes JL, Klise S, Krege JH, Case M, Khanna R, Vasudeva R et al (2019) Interim results of a prospective, randomized, open-label, phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study). Cephalalgia. 39(11):1343–1357
Article
PubMed
PubMed Central
Google Scholar
Pascual J, Muñoz P (2005) Correlation between lipophilicity and triptan outcomes. Headache. 45(1):3–6
Article
PubMed
Google Scholar
Lundblad C, Haanes KA, Grände G, Edvinsson L (2015) Experimental inflammation following dural application of complete Freund’s adjuvant or inflammatory soup does not alter brain and trigeminal microvascular passage. J Headache Pain 16(1):91
Article
PubMed
PubMed Central
Google Scholar
Noseda R, Schain AJ, Melo-Carrillo A, Tien J, Stratton J, Mai F et al (2020) Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. Cephalalgia 40(3):229–240
Article
PubMed
Google Scholar
Hoskin KL, Kaube H, Goadsby PJ (1996) Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine: a c-Fos and electrophysiological study. Brain 119(1):249–256
Article
PubMed
Google Scholar
Hoskin KL, Lambert GA, Donaldson C, Zagami AS (2004) The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat. Brain Res 998(1):91–99
Article
CAS
PubMed
Google Scholar
Messlinger K (2018) The big CGRP flood-sources, sinks and signalling sites in the trigeminovascular system. J Headache Pain 19(1):1–7
Article
CAS
Google Scholar
Messlinger K, Russo AF (2019) Current understanding of trigeminal ganglion structure and function in headache. Cephalalgia. 39(13):1661–1674
Article
PubMed
Google Scholar
Messlinger K, Balcziak LK, Russo AF (2020) Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators. J Neural Transm 127(4):431–444
Article
PubMed
Google Scholar
Burnstock G (1981) Pathophysiology of migraine: a new hypothesis. Lancet. 317(8235):1397–1399
Article
Google Scholar
Burnstock G, Ralevic V (2014) Purinergic signaling and blood vessels in health and disease. Pharmacol Rev 66(1):102–192
Article
PubMed
Google Scholar
Giniatullin R, Nistri A, Fabbretti E (2008) Molecular mechanisms of sensitization of pain-transducing P2X 3 receptors by the migraine mediators CGRP and NGF. Mol Neurobiol 37(1):83–90
Article
CAS
PubMed
Google Scholar
Yegutkin GG, Guerrero-Toro C, Kilinc E, Koroleva K, Ishchenko Y, Abushik P et al (2016) Nucleotide homeostasis and purinergic nociceptive signaling in rat meninges in migraine-like conditions. Purinergic Signal 12(3):561–574
Article
CAS
PubMed
PubMed Central
Google Scholar
Edvinsson JCA, Grell A-S, Warfvinge K, Sheykhzade M, Edvinsson L, Haanes KA (2020) Differences in pituitary adenylate cyclase-activating peptide and calcitonin gene-related peptide release in the trigeminovascular system. Cephalalgia 40(12):1296–1309
Article
PubMed
Google Scholar